Reports
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States
Americas
Future Market Insights, Inc.
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
MEA
Future Market Insights
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom
Asia Pacific
Future Market Insights
IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India
The bone marrow transplant market is anticipated to flourish at an average CAGR of 3.4% between 2023 and 2033. The market is expected to hold a market share of US$ 14.86 billion by 2033, while the market is likely to reach a value of US$ 10.65 billion in 2023. A historical CAGR of 2.5% has been recorded by the experts of Future Market Insights for the market concerned.
The hematopoietic stem cell is a soft vascular tissue in the interiors of long bones, and a bone marrow transplant is identified as the procedure to replace the damaged or destroyed bone marrow with healthy bone marrow stem cells.
Attributes | Details |
---|---|
Bone Marrow Transplant Market CAGR (2023 to 2033) | 3.4% |
Bone Marrow Transplant Market Size (2023) | US$ 10.65 billion |
Bone Marrow Transplant Market Size (2033) | US$ 14.86 billion |
The bone marrow transplant procedure is prescribed for the treatment of advanced stages of leukemia, Hodgkin, and non-Hodgkin lymphomas, multiple myeloma, aplastic and sickle cell anemia, thalassemia, and other diseases. Increasing awareness, combined with an increase in initiatives run by healthcare practitioners, is majorly responsible for the global growth of the market.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The market is anticipated to have mixed dynamics contributing to the bearish propulsion of the bone marrow transplant market. Several factors impacting the expansion of the market are identified during the study.
Besides the factors influencing growth, it is also identified that certain aspects can limit growth and curb the pace of growth further in the market.
Drivers:
Restraints:
Country | Revenue Share % (2022) |
---|---|
United States | 30.3% |
Germany | 11.9% |
Japan | 2/0% |
North America | 32.3% |
Europe | 53.1% |
Country | CAGR % (2023 to 2033) |
---|---|
China | 4.2% |
India | 3.4% |
United Kingdom | 2.4% |
Australia | 3.1% |
North America is projected to secure steady bone marrow transplant market growth during the forecast period. The region cumulatively held 32.3% market share of the global bone marrow transplant market in 2022.
The factors attributing to the growth can be mentioned as follows:
Europe is projected to dominate the global market for bone marrow transplants during the forecast period. At present, Europe holds 53.1% of the total market share for bone marrow transplants worldwide in 2022.
The reasons owing for such extensive market expansion are mentioned below:
Category | By Transplant Type |
---|---|
Leading Segment | Autologous |
Market Share (2022) | 54.5% |
Category | By End User |
---|---|
Leading Segment | Hospital |
Market Share (2022) | 90.3% |
The start-ups in the bone marrow transplant market are indulging in collaborations and continually making innovations to stem cell transplant procedures to further make it convenient and cost-efficient for the population.
Company Name | Magenta Therapeutics, Cambridge (United States) |
---|---|
Total Funding | US$ 151 million |
Description | Developed stem cell-based therapies for autoimmune disease, genetic blood disorders, and cancer. The company has developed stem cell transplants by using targeted antibodies, stem cell harvesting using new biologic agents, and increasing stem cell numbers by targeting self-renewal pathways. |
Company Name | Kiadis Pharma, Amsterdam (Netherlands) |
---|---|
Total Funding | US$ 33 million |
Description | Kiadis Pharma is a developer of therapeutic solutions for hematopoietic stem cell transplants. It is focused on developing solutions for complications and limitations of hematopoietic stem cell transplants (HSCT) in blood cancer patients. The company uses all depleted T-cell immunotherapeutics (ATIR) to support the patient’s newly transplanted immune system before it becomes fully functional. This enables better acceptance of even haploidentical (or lower) stem cell donors. Kiadis is investigating the use of ATIR in leukemia and thalassemia. |
Company Name | Talaris, Boston |
---|---|
Total Funding | US$ 215 million |
Description | Talaris Therapeutics is involved in developing single-dose cell therapy to treat living donor kidney transplant tolerance. They have developed a proprietary technology that allows candidates for bone marrow transplants to receive hematopoietic stem cells (HSCs). The lead candidate, FCR001, is in phase III clinical trial, which is being investigated for living donor kidney transplant tolerance. |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The bone marrow transplant market is highly competitive and consists of several leading players. To increase their global market presence, market leaders are engaging in various product launches, mergers and acquisitions, and development activities focusing on orthopedic surgical treatments.
Recent Developments
Some Recent Developments Identified in the Analysis are:
The market is anticipated to be valued at US$ 10.65 billion in 2023.
The global market advanced at a 2.5% HCAGR from 2018 to 2022.
Up until 2033, the market is anticipated to thrive at a CAGR of 3.4%.
Potentially holding 32.3% of the market in North America.
The market has been dominated by Europe, 53.1%.
By 2033, the market is anticipated to be worth US$14.86 billion.
The autologous category to escalate to a market share of 54.5% in 2023.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Transplant Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Transplant Type, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Transplant Type, 2023 to 2033 5.3.1. Autologous 5.3.2. Allogeneic 5.4. Y-o-Y Growth Trend Analysis By Transplant Type, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Transplant Type, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Disease Indication 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Disease Indication, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Disease Indication, 2023 to 2033 6.3.1. Leukemia 6.3.2. Lymphoma 6.3.3. Myeloma 6.3.4. Others 6.4. Y-o-Y Growth Trend Analysis By Disease Indication, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Disease Indication, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-User 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By End-User , 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End-User , 2023 to 2033 7.3.1. Hospitals 7.3.2. Multispecialty Clinics 7.3.3. Ambulatory Surgical Centers 7.3.4. Others 7.4. Y-o-Y Growth Trend Analysis By End-User , 2018 to 2022 7.5. Absolute $ Opportunity Analysis By End-User , 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 8.3.1. North America 8.3.2. Latin America 8.3.3. Western Europe 8.3.4. Eastern Europe 8.3.5. South Asia and Pacific 8.3.6. East Asia 8.3.7. Middle East and Africa 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. USA. 9.2.1.2. Canada 9.2.2. By Transplant Type 9.2.3. By Disease Indication 9.2.4. By End-User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Transplant Type 9.3.3. By Disease Indication 9.3.4. By End-User 9.4. Key Takeaways 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Transplant Type 10.2.3. By Disease Indication 10.2.4. By End-User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Transplant Type 10.3.3. By Disease Indication 10.3.4. By End-User 10.4. Key Takeaways 11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. United Kingdom. 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Western Europe 11.2.2. By Transplant Type 11.2.3. By Disease Indication 11.2.4. By End-User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Transplant Type 11.3.3. By Disease Indication 11.3.4. By End-User 11.4. Key Takeaways 12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. Poland 12.2.1.2. Russia 12.2.1.3. Czech Republic 12.2.1.4. Romania 12.2.1.5. Rest of Eastern Europe 12.2.2. By Transplant Type 12.2.3. By Disease Indication 12.2.4. By End-User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Transplant Type 12.3.3. By Disease Indication 12.3.4. By End-User 12.4. Key Takeaways 13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. India 13.2.1.2. Bangladesh 13.2.1.3. Australia 13.2.1.4. New Zealand 13.2.1.5. Rest of South Asia and Pacific 13.2.2. By Transplant Type 13.2.3. By Disease Indication 13.2.4. By End-User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Transplant Type 13.3.3. By Disease Indication 13.3.4. By End-User 13.4. Key Takeaways 14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. China 14.2.1.2. Japan 14.2.1.3. South Korea 14.2.2. By Transplant Type 14.2.3. By Disease Indication 14.2.4. By End-User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Transplant Type 14.3.3. By Disease Indication 14.3.4. By End-User 14.4. Key Takeaways 15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Israel 15.2.1.4. Rest of MEA 15.2.2. By Transplant Type 15.2.3. By Disease Indication 15.2.4. By End-User 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Transplant Type 15.3.3. By Disease Indication 15.3.4. By End-User 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. USA. 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2022 16.1.2.1. By Transplant Type 16.1.2.2. By Disease Indication 16.1.2.3. By End-User 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2022 16.2.2.1. By Transplant Type 16.2.2.2. By Disease Indication 16.2.2.3. By End-User 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2022 16.3.2.1. By Transplant Type 16.3.2.2. By Disease Indication 16.3.2.3. By End-User 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2022 16.4.2.1. By Transplant Type 16.4.2.2. By Disease Indication 16.4.2.3. By End-User 16.5. Germany 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2022 16.5.2.1. By Transplant Type 16.5.2.2. By Disease Indication 16.5.2.3. By End-User 16.6. United Kingdom. 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2022 16.6.2.1. By Transplant Type 16.6.2.2. By Disease Indication 16.6.2.3. By End-User 16.7. France 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2022 16.7.2.1. By Transplant Type 16.7.2.2. By Disease Indication 16.7.2.3. By End-User 16.8. Spain 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2022 16.8.2.1. By Transplant Type 16.8.2.2. By Disease Indication 16.8.2.3. By End-User 16.9. Italy 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2022 16.9.2.1. By Transplant Type 16.9.2.2. By Disease Indication 16.9.2.3. By End-User 16.10. Poland 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2022 16.10.2.1. By Transplant Type 16.10.2.2. By Disease Indication 16.10.2.3. By End-User 16.11. Russia 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2022 16.11.2.1. By Transplant Type 16.11.2.2. By Disease Indication 16.11.2.3. By End-User 16.12. Czech Republic 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2022 16.12.2.1. By Transplant Type 16.12.2.2. By Disease Indication 16.12.2.3. By End-User 16.13. Romania 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2022 16.13.2.1. By Transplant Type 16.13.2.2. By Disease Indication 16.13.2.3. By End-User 16.14. India 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2022 16.14.2.1. By Transplant Type 16.14.2.2. By Disease Indication 16.14.2.3. By End-User 16.15. Bangladesh 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2022 16.15.2.1. By Transplant Type 16.15.2.2. By Disease Indication 16.15.2.3. By End-User 16.16. Australia 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2022 16.16.2.1. By Transplant Type 16.16.2.2. By Disease Indication 16.16.2.3. By End-User 16.17. New Zealand 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2022 16.17.2.1. By Transplant Type 16.17.2.2. By Disease Indication 16.17.2.3. By End-User 16.18. China 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2022 16.18.2.1. By Transplant Type 16.18.2.2. By Disease Indication 16.18.2.3. By End-User 16.19. Japan 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2022 16.19.2.1. By Transplant Type 16.19.2.2. By Disease Indication 16.19.2.3. By End-User 16.20. South Korea 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2022 16.20.2.1. By Transplant Type 16.20.2.2. By Disease Indication 16.20.2.3. By End-User 16.21. GCC Countries 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2022 16.21.2.1. By Transplant Type 16.21.2.2. By Disease Indication 16.21.2.3. By End-User 16.22. South Africa 16.22.1. Pricing Analysis 16.22.2. Market Share Analysis, 2022 16.22.2.1. By Transplant Type 16.22.2.2. By Disease Indication 16.22.2.3. By End-User 16.23. Israel 16.23.1. Pricing Analysis 16.23.2. Market Share Analysis, 2022 16.23.2.1. By Transplant Type 16.23.2.2. By Disease Indication 16.23.2.3. By End-User 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Transplant Type 17.3.3. By Disease Indication 17.3.4. By End-User 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Lonza Group Ltd. 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.2. Merck Millipore Corporation 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.3. Sanofi-Aventis LLC. 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.4. AllCells LLC. 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.5. STEMCELL Technologies 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.6. ATCC Inc. 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.7. Hemacare Corporation 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.8. Cellular Dynamics International 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.9. ReachBio LLC. 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.10. Conversant Bio, ABM Inc. 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 18.1.11. PromoCell GmbH 18.1.11.1. Overview 18.1.11.2. Product Portfolio 18.1.11.3. Profitability by Market Segments 18.1.11.4. Sales Footprint 18.1.11.5. Strategy Overview 18.1.11.5.1. Marketing Strategy 18.1.12. Cruline Human biospecimen PRO 18.1.12.1. Overview 18.1.12.2. Product Portfolio 18.1.12.3. Profitability by Market Segments 18.1.12.4. Sales Footprint 18.1.12.5. Strategy Overview 18.1.12.5.1. Marketing Strategy 18.1.13. Lifeline Cell Technology 18.1.13.1. Overview 18.1.13.2. Product Portfolio 18.1.13.3. Profitability by Market Segments 18.1.13.4. Sales Footprint 18.1.13.5. Strategy Overview 18.1.13.5.1. Marketing Strategy 18.1.14. Mesoblast Ltd. 18.1.14.1. Overview 18.1.14.2. Product Portfolio 18.1.14.3. Profitability by Market Segments 18.1.14.4. Sales Footprint 18.1.14.5. Strategy Overview 18.1.14.5.1. Marketing Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033 Table 2: Global Market Value (US$ Million) Forecast by Transplant Type, 2018 to 2033 Table 3: Global Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033 Table 4: Global Market Value (US$ Million) Forecast by End-User , 2018 to 2033 Table 5: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 6: North America Market Value (US$ Million) Forecast by Transplant Type, 2018 to 2033 Table 7: North America Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033 Table 8: North America Market Value (US$ Million) Forecast by End-User , 2018 to 2033 Table 9: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 10: Latin America Market Value (US$ Million) Forecast by Transplant Type, 2018 to 2033 Table 11: Latin America Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033 Table 12: Latin America Market Value (US$ Million) Forecast by End-User , 2018 to 2033 Table 13: Western Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 14: Western Europe Market Value (US$ Million) Forecast by Transplant Type, 2018 to 2033 Table 15: Western Europe Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033 Table 16: Western Europe Market Value (US$ Million) Forecast by End-User , 2018 to 2033 Table 17: Eastern Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 18: Eastern Europe Market Value (US$ Million) Forecast by Transplant Type, 2018 to 2033 Table 19: Eastern Europe Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033 Table 20: Eastern Europe Market Value (US$ Million) Forecast by End-User , 2018 to 2033 Table 21: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 22: South Asia and Pacific Market Value (US$ Million) Forecast by Transplant Type, 2018 to 2033 Table 23: South Asia and Pacific Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033 Table 24: South Asia and Pacific Market Value (US$ Million) Forecast by End-User , 2018 to 2033 Table 25: East Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 26: East Asia Market Value (US$ Million) Forecast by Transplant Type, 2018 to 2033 Table 27: East Asia Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033 Table 28: East Asia Market Value (US$ Million) Forecast by End-User , 2018 to 2033 Table 29: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 30: Middle East and Africa Market Value (US$ Million) Forecast by Transplant Type, 2018 to 2033 Table 31: Middle East and Africa Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033 Table 32: Middle East and Africa Market Value (US$ Million) Forecast by End-User , 2018 to 2033
Figure 1: Global Market Value (US$ Million) by Transplant Type, 2023 to 2033 Figure 2: Global Market Value (US$ Million) by Disease Indication, 2023 to 2033 Figure 3: Global Market Value (US$ Million) by End-User , 2023 to 2033 Figure 4: Global Market Value (US$ Million) by Region, 2023 to 2033 Figure 5: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033 Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033 Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033 Figure 8: Global Market Value (US$ Million) Analysis by Transplant Type, 2018 to 2033 Figure 9: Global Market Value Share (%) and BPS Analysis by Transplant Type, 2023 to 2033 Figure 10: Global Market Y-o-Y Growth (%) Projections by Transplant Type, 2023 to 2033 Figure 11: Global Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033 Figure 12: Global Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033 Figure 13: Global Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033 Figure 14: Global Market Value (US$ Million) Analysis by End-User , 2018 to 2033 Figure 15: Global Market Value Share (%) and BPS Analysis by End-User , 2023 to 2033 Figure 16: Global Market Y-o-Y Growth (%) Projections by End-User , 2023 to 2033 Figure 17: Global Market Attractiveness by Transplant Type, 2023 to 2033 Figure 18: Global Market Attractiveness by Disease Indication, 2023 to 2033 Figure 19: Global Market Attractiveness by End-User , 2023 to 2033 Figure 20: Global Market Attractiveness by Region, 2023 to 2033 Figure 21: North America Market Value (US$ Million) by Transplant Type, 2023 to 2033 Figure 22: North America Market Value (US$ Million) by Disease Indication, 2023 to 2033 Figure 23: North America Market Value (US$ Million) by End-User , 2023 to 2033 Figure 24: North America Market Value (US$ Million) by Country, 2023 to 2033 Figure 25: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 28: North America Market Value (US$ Million) Analysis by Transplant Type, 2018 to 2033 Figure 29: North America Market Value Share (%) and BPS Analysis by Transplant Type, 2023 to 2033 Figure 30: North America Market Y-o-Y Growth (%) Projections by Transplant Type, 2023 to 2033 Figure 31: North America Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033 Figure 32: North America Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033 Figure 33: North America Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033 Figure 34: North America Market Value (US$ Million) Analysis by End-User , 2018 to 2033 Figure 35: North America Market Value Share (%) and BPS Analysis by End-User , 2023 to 2033 Figure 36: North America Market Y-o-Y Growth (%) Projections by End-User , 2023 to 2033 Figure 37: North America Market Attractiveness by Transplant Type, 2023 to 2033 Figure 38: North America Market Attractiveness by Disease Indication, 2023 to 2033 Figure 39: North America Market Attractiveness by End-User , 2023 to 2033 Figure 40: North America Market Attractiveness by Country, 2023 to 2033 Figure 41: Latin America Market Value (US$ Million) by Transplant Type, 2023 to 2033 Figure 42: Latin America Market Value (US$ Million) by Disease Indication, 2023 to 2033 Figure 43: Latin America Market Value (US$ Million) by End-User , 2023 to 2033 Figure 44: Latin America Market Value (US$ Million) by Country, 2023 to 2033 Figure 45: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 48: Latin America Market Value (US$ Million) Analysis by Transplant Type, 2018 to 2033 Figure 49: Latin America Market Value Share (%) and BPS Analysis by Transplant Type, 2023 to 2033 Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Transplant Type, 2023 to 2033 Figure 51: Latin America Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033 Figure 52: Latin America Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033 Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033 Figure 54: Latin America Market Value (US$ Million) Analysis by End-User , 2018 to 2033 Figure 55: Latin America Market Value Share (%) and BPS Analysis by End-User , 2023 to 2033 Figure 56: Latin America Market Y-o-Y Growth (%) Projections by End-User , 2023 to 2033 Figure 57: Latin America Market Attractiveness by Transplant Type, 2023 to 2033 Figure 58: Latin America Market Attractiveness by Disease Indication, 2023 to 2033 Figure 59: Latin America Market Attractiveness by End-User , 2023 to 2033 Figure 60: Latin America Market Attractiveness by Country, 2023 to 2033 Figure 61: Western Europe Market Value (US$ Million) by Transplant Type, 2023 to 2033 Figure 62: Western Europe Market Value (US$ Million) by Disease Indication, 2023 to 2033 Figure 63: Western Europe Market Value (US$ Million) by End-User , 2023 to 2033 Figure 64: Western Europe Market Value (US$ Million) by Country, 2023 to 2033 Figure 65: Western Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 66: Western Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 67: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 68: Western Europe Market Value (US$ Million) Analysis by Transplant Type, 2018 to 2033 Figure 69: Western Europe Market Value Share (%) and BPS Analysis by Transplant Type, 2023 to 2033 Figure 70: Western Europe Market Y-o-Y Growth (%) Projections by Transplant Type, 2023 to 2033 Figure 71: Western Europe Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033 Figure 72: Western Europe Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033 Figure 73: Western Europe Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033 Figure 74: Western Europe Market Value (US$ Million) Analysis by End-User , 2018 to 2033 Figure 75: Western Europe Market Value Share (%) and BPS Analysis by End-User , 2023 to 2033 Figure 76: Western Europe Market Y-o-Y Growth (%) Projections by End-User , 2023 to 2033 Figure 77: Western Europe Market Attractiveness by Transplant Type, 2023 to 2033 Figure 78: Western Europe Market Attractiveness by Disease Indication, 2023 to 2033 Figure 79: Western Europe Market Attractiveness by End-User , 2023 to 2033 Figure 80: Western Europe Market Attractiveness by Country, 2023 to 2033 Figure 81: Eastern Europe Market Value (US$ Million) by Transplant Type, 2023 to 2033 Figure 82: Eastern Europe Market Value (US$ Million) by Disease Indication, 2023 to 2033 Figure 83: Eastern Europe Market Value (US$ Million) by End-User , 2023 to 2033 Figure 84: Eastern Europe Market Value (US$ Million) by Country, 2023 to 2033 Figure 85: Eastern Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 86: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 87: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 88: Eastern Europe Market Value (US$ Million) Analysis by Transplant Type, 2018 to 2033 Figure 89: Eastern Europe Market Value Share (%) and BPS Analysis by Transplant Type, 2023 to 2033 Figure 90: Eastern Europe Market Y-o-Y Growth (%) Projections by Transplant Type, 2023 to 2033 Figure 91: Eastern Europe Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033 Figure 92: Eastern Europe Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033 Figure 93: Eastern Europe Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033 Figure 94: Eastern Europe Market Value (US$ Million) Analysis by End-User , 2018 to 2033 Figure 95: Eastern Europe Market Value Share (%) and BPS Analysis by End-User , 2023 to 2033 Figure 96: Eastern Europe Market Y-o-Y Growth (%) Projections by End-User , 2023 to 2033 Figure 97: Eastern Europe Market Attractiveness by Transplant Type, 2023 to 2033 Figure 98: Eastern Europe Market Attractiveness by Disease Indication, 2023 to 2033 Figure 99: Eastern Europe Market Attractiveness by End-User , 2023 to 2033 Figure 100: Eastern Europe Market Attractiveness by Country, 2023 to 2033 Figure 101: South Asia and Pacific Market Value (US$ Million) by Transplant Type, 2023 to 2033 Figure 102: South Asia and Pacific Market Value (US$ Million) by Disease Indication, 2023 to 2033 Figure 103: South Asia and Pacific Market Value (US$ Million) by End-User , 2023 to 2033 Figure 104: South Asia and Pacific Market Value (US$ Million) by Country, 2023 to 2033 Figure 105: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 106: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 107: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 108: South Asia and Pacific Market Value (US$ Million) Analysis by Transplant Type, 2018 to 2033 Figure 109: South Asia and Pacific Market Value Share (%) and BPS Analysis by Transplant Type, 2023 to 2033 Figure 110: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Transplant Type, 2023 to 2033 Figure 111: South Asia and Pacific Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033 Figure 112: South Asia and Pacific Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033 Figure 113: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033 Figure 114: South Asia and Pacific Market Value (US$ Million) Analysis by End-User , 2018 to 2033 Figure 115: South Asia and Pacific Market Value Share (%) and BPS Analysis by End-User , 2023 to 2033 Figure 116: South Asia and Pacific Market Y-o-Y Growth (%) Projections by End-User , 2023 to 2033 Figure 117: South Asia and Pacific Market Attractiveness by Transplant Type, 2023 to 2033 Figure 118: South Asia and Pacific Market Attractiveness by Disease Indication, 2023 to 2033 Figure 119: South Asia and Pacific Market Attractiveness by End-User , 2023 to 2033 Figure 120: South Asia and Pacific Market Attractiveness by Country, 2023 to 2033 Figure 121: East Asia Market Value (US$ Million) by Transplant Type, 2023 to 2033 Figure 122: East Asia Market Value (US$ Million) by Disease Indication, 2023 to 2033 Figure 123: East Asia Market Value (US$ Million) by End-User , 2023 to 2033 Figure 124: East Asia Market Value (US$ Million) by Country, 2023 to 2033 Figure 125: East Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 126: East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 127: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 128: East Asia Market Value (US$ Million) Analysis by Transplant Type, 2018 to 2033 Figure 129: East Asia Market Value Share (%) and BPS Analysis by Transplant Type, 2023 to 2033 Figure 130: East Asia Market Y-o-Y Growth (%) Projections by Transplant Type, 2023 to 2033 Figure 131: East Asia Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033 Figure 132: East Asia Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033 Figure 133: East Asia Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033 Figure 134: East Asia Market Value (US$ Million) Analysis by End-User , 2018 to 2033 Figure 135: East Asia Market Value Share (%) and BPS Analysis by End-User , 2023 to 2033 Figure 136: East Asia Market Y-o-Y Growth (%) Projections by End-User , 2023 to 2033 Figure 137: East Asia Market Attractiveness by Transplant Type, 2023 to 2033 Figure 138: East Asia Market Attractiveness by Disease Indication, 2023 to 2033 Figure 139: East Asia Market Attractiveness by End-User , 2023 to 2033 Figure 140: East Asia Market Attractiveness by Country, 2023 to 2033 Figure 141: Middle East and Africa Market Value (US$ Million) by Transplant Type, 2023 to 2033 Figure 142: Middle East and Africa Market Value (US$ Million) by Disease Indication, 2023 to 2033 Figure 143: Middle East and Africa Market Value (US$ Million) by End-User , 2023 to 2033 Figure 144: Middle East and Africa Market Value (US$ Million) by Country, 2023 to 2033 Figure 145: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 146: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 147: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 148: Middle East and Africa Market Value (US$ Million) Analysis by Transplant Type, 2018 to 2033 Figure 149: Middle East and Africa Market Value Share (%) and BPS Analysis by Transplant Type, 2023 to 2033 Figure 150: Middle East and Africa Market Y-o-Y Growth (%) Projections by Transplant Type, 2023 to 2033 Figure 151: Middle East and Africa Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033 Figure 152: Middle East and Africa Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033 Figure 153: Middle East and Africa Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033 Figure 154: Middle East and Africa Market Value (US$ Million) Analysis by End-User , 2018 to 2033 Figure 155: Middle East and Africa Market Value Share (%) and BPS Analysis by End-User , 2023 to 2033 Figure 156: Middle East and Africa Market Y-o-Y Growth (%) Projections by End-User , 2023 to 2033 Figure 157: Middle East and Africa Market Attractiveness by Transplant Type, 2023 to 2033 Figure 158: Middle East and Africa Market Attractiveness by Disease Indication, 2023 to 2033 Figure 159: Middle East and Africa Market Attractiveness by End-User , 2023 to 2033 Figure 160: Middle East and Africa Market Attractiveness by Country, 2023 to 2033
Recommendations
Explore Healthcare Insights
View Reports